Clinical Trial Update: Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting the completion of a study evaluating 5-aminolevulinic acid given before cardiac surgery, including coronary artery bypass graftin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Coronary Artery Disease
• Mitral Valve Disease

Drugs mentioned

• 5-aminolevulinic acid (5-ALA) (5-aminolevulinic acid)

Snippet

Sponsor: University of Oxford | Conditions: Cardiac Surgical Procedures, Coronary Artery Bypass | Phase 2 | Status: COMPLETED